- In November 2023, W&H expanded its hygiene portfolio by introducing the new Lexa Plus Class B sterilizer and the technologically advanced Assistina One maintenance device. The Lexa Plus Class B sterilizer offers enhanced capacity, energy-saving fast cycles, and automatic water filling, making it a highly efficient and reliable option for dental practices. The Assistina One maintenance device speeds up daily operation with its quick connect system, fast cycle time, and thorough maintenance capabilities, ensuring optimal care for dental handpieces and other instruments2. These additions bring added peace of mind to reprocessing and infection prevention in dental practice workflows
- In June 2023, Becton, Dickinson, and Company (BD) launched a new automated instrument designed to prepare samples for clinical diagnostics using flow cytometry. This innovative system, known as the BD FACSDuet™ Premium Sample Preparation System, leverages liquid-handling robotics to automate the entire sample preparation process, including cocktailing, washing, and centrifuging. The system is integrated with the BD FACSLyric™ Clinical Flow Cytometry System, enabling a complete "walkaway" workflow solution that requires fewer manual steps and resources. This advancement aims to improve standardization and reproducibility in cellular diagnostics, allowing healthcare professionals to focus more on analyzing and interpreting samples to impact patient outcomes
- In May 2023, Becton, Dickinson, and Company (BD) announced the worldwide commercial launch of the BD FACSDiscover™ S8 Cell Sorter, a groundbreaking cell sorting instrument featuring two breakthrough technologies. This innovative device combines spectral flow cytometry with real-time imaging technology, enabling researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments. The BD FACSDiscover™ S8 Cell Sorter integrates BD CellView™ Image Technology and BD SpectralFX™ Technology, allowing scientists to achieve full-spectrum cell sorting and obtain detailed microscopic images of individual cells. This combination of technologies enhances the capabilities of researchers, transforming cell analysis and sorting by providing spatial and morphological insights in real-time
- In February 2023, BioReference Health LLC announced that it would be among the first commercial laboratories to offer the CINtec PLUS Cytology test from Roche Diagnostics. This test is notable for being the only FDA-approved dual-stain triage test designed for patients who have tested positive for high-risk human papillomavirus (HPV). The CINtec PLUS Cytology test uses dual-stain biomarker technology to simultaneously detect p16 and Ki-67 in women with HPV-positive results, providing a more accurate assessment of the risk for cervical pre-cancer. BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
- In August 2022, Becton, Dickinson, and Company (BD) announced a collaboration agreement with Labcorp, a leading global life sciences company. This partnership aims to develop, manufacture, market, and commercialize flow cytometry-based companion diagnostics (CDx) designed to match patients with life-changing treatments for cancer and other diseases. The collaboration combines the strengths of both companies to advance flow cytometry as a crucial companion diagnostic tool, enhancing the ability to select optimal first-line therapies for patients and improving treatment outcomes
